These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 35433883)

  • 1. Estrogen and Cardiovascular Health.
    den Ruijter HM; Kararigas G
    Front Cardiovasc Med; 2022; 9():886592. PubMed ID: 35433883
    [No Abstract]   [Full Text] [Related]  

  • 2. Impact of sex hormone metabolism on the vascular effects of menopausal hormone therapy in cardiovascular disease.
    Masood DE; Roach EC; Beauregard KG; Khalil RA
    Curr Drug Metab; 2010 Oct; 11(8):693-714. PubMed ID: 21189141
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Managing the risk of venous thromboembolism in transgender adults undergoing hormone therapy.
    Goldstein Z; Khan M; Reisman T; Safer JD
    J Blood Med; 2019; 10():209-216. PubMed ID: 31372078
    [No Abstract]   [Full Text] [Related]  

  • 4. Cardiovascular Risk Associated With Gender Affirming Hormone Therapy in Transgender Population.
    Aranda G; Halperin I; Gomez-Gil E; Hanzu FA; Seguí N; Guillamon A; Mora M
    Front Endocrinol (Lausanne); 2021; 12():718200. PubMed ID: 34659112
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gender-Affirming Hormone Therapy, Vascular Health and Cardiovascular Disease in Transgender Adults.
    Connelly PJ; Marie Freel E; Perry C; Ewan J; Touyz RM; Currie G; Delles C
    Hypertension; 2019 Dec; 74(6):1266-1274. PubMed ID: 31656099
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cardiac arrhythmias secondary to hormone therapy in trans women.
    Wamboldt R; Haseeb S; Waddington A; Baranchuk A
    Expert Rev Cardiovasc Ther; 2019 May; 17(5):335-343. PubMed ID: 30987471
    [No Abstract]   [Full Text] [Related]  

  • 7. Hormone therapy for transgender patients.
    Unger CA
    Transl Androl Urol; 2016 Dec; 5(6):877-884. PubMed ID: 28078219
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hematology reference intervals for transgender adults on stable hormone therapy.
    Greene DN; McPherson GW; Rongitsch J; Imborek KL; Schmidt RL; Humble RM; Nisly N; Dole NJ; Dane SK; Frerichs J; Krasowski MD
    Clin Chim Acta; 2019 May; 492():84-90. PubMed ID: 30771301
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modulation of cardiac hypertrophy by estrogens.
    Pelzer T; Shamim A; Wölfges S; Schumann M; Neyses L
    Adv Exp Med Biol; 1997; 432():83-9. PubMed ID: 9433514
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Blood pressure dynamics after pubertal suppression with gonadotropin-releasing hormone analogs followed by estradiol treatment in transgender female adolescents: a pilot study.
    Perl L; Elkon-Tamir E; Segev-Becker A; Israeli G; Brener A; Oren A
    J Pediatr Endocrinol Metab; 2021 Jun; 34(6):741-745. PubMed ID: 33823098
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic and pharmacologic strategies to determine the function of estrogen receptor alpha and estrogen receptor beta in cardiovascular system.
    Arias-Loza PA; Jazbutyte V; Pelzer T
    Gend Med; 2008; 5 Suppl A():S34-45. PubMed ID: 18395682
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prescribing for transgender patients.
    Tomlins L
    Aust Prescr; 2019 Feb; 42(1):10-13. PubMed ID: 30765903
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CARDIOVASCULAR HEALTH MAINTENANCE IN AGING INDIVIDUALS: THE IMPLICATIONS FOR TRANSGENDER MEN AND WOMEN ON HORMONE THERAPY.
    Slack DJ; Safer JD
    Endocr Pract; 2021 Jan; 27(1):63-70. PubMed ID: 33475503
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessment of Gender-Affirming Hormone Therapy Requirements.
    Fernandez JD; Kendjorsky K; Narla A; Villasante-Tezanos AG; Tannock LR
    LGBT Health; 2019 Apr; 6(3):101-106. PubMed ID: 30810452
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cross-sex Hormones and Acute Cardiovascular Events in Transgender Persons: A Cohort Study.
    Getahun D; Nash R; Flanders WD; Baird TC; Becerra-Culqui TA; Cromwell L; Hunkeler E; Lash TL; Millman A; Quinn VP; Robinson B; Roblin D; Silverberg MJ; Safer J; Slovis J; Tangpricha V; Goodman M
    Ann Intern Med; 2018 Aug; 169(4):205-213. PubMed ID: 29987313
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cardiovascular Disease Among Transgender Adults Receiving Hormone Therapy: A Narrative Review.
    Streed CG; Harfouch O; Marvel F; Blumenthal RS; Martin SS; Mukherjee M
    Ann Intern Med; 2017 Aug; 167(4):256-267. PubMed ID: 28738421
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sex differences in myocardial metabolism and cardiac function: an emerging concept.
    Wittnich C; Tan L; Wallen J; Belanger M
    Pflugers Arch; 2013 May; 465(5):719-29. PubMed ID: 23404619
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardiovascular health in transgender people.
    Irwig MS
    Rev Endocr Metab Disord; 2018 Sep; 19(3):243-251. PubMed ID: 30073551
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Estrogen-induced gallstone pancreatitis in a transgender female.
    Freier E; Kassel L; Rand J; Chinnakotla B
    Am J Health Syst Pharm; 2021 Sep; 78(18):1674-1680. PubMed ID: 33948625
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of Surgical Risk With Exogenous Hormone Use in Transgender Patients: A Systematic Review.
    Boskey ER; Taghinia AH; Ganor O
    JAMA Surg; 2019 Feb; 154(2):159-169. PubMed ID: 30516808
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.